Tg(hs348-cre/ERT2,-GFP)1Jlr
Transgene Detail
|
|
| Symbol: |
Tg(hs348-cre/ERT2,-GFP)1Jlr |
| Name: |
transgene insertion 1, John L R Rubenstein |
| MGI ID: |
MGI:6160931 |
| Synonyms: |
348-CreER-IRES-GFP, Tg(RALGAPA1-cre/ERT2, GFP)1Jlr |
| Transgene: |
Tg(hs348-cre/ERT2,-GFP)1Jlr Location: unknown
|
| Alliance: |
Tg(hs348-cre/ERT2,-GFP)1Jlr page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase, Reporter) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(hs348-cre/ERT2,-GFP)1Jlr expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Note |
| human |
hs348 |
|
|
| |
|
Mutation details: This transgene contains the human enhancer element hs348 -- which resides on human Chr 14 within the Ral GTPase activating protein catalytic alpha subunit 1 (RALGAPA1) locus -- followed by a mouse minimal Hsp68 promoter, the cre/ERT2 fusion gene, an internal ribosomal entry site (IRES), and a green fluorescent protein reporter gene. The fusion gene encodes Cre recombinase joined to a modified ligand-binding domain of the human estrogen receptor that preferentially binds tamoxifen or 4-hydroxytamoxifen, but not endogenous 17beta-estradiol; upon binding to tamoxifen, the cre/ERT2 protein is translocated to the nucleus.
(J:214335)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
hs348
(human)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:214335 Pattabiraman K, et al., Transcriptional regulation of enhancers active in protodomains of the developing cerebral cortex. Neuron. 2014 Jun 4;82(5):989-1003 |
| All: |
1 reference(s) |
|
Analysis Tools
